These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12480261)

  • 21. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
    Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
    Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.
    Abeler-Dörner L; Rieger CC; Berger B; Weyd H; Gräf D; Pfrang S; Tarner IH; Schwarting A; Lorenz HM; Müller-Ladner U; Krammer PH; Kuhn A
    J Rheumatol; 2013 Oct; 40(10):1683-96. PubMed ID: 24037549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
    Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
    Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus.
    Bayry J; Lacroix-Desmazes S; Delignat S; Mouthon L; Weill B; Kazatchkine MD; Kaveri SV
    Arthritis Rheum; 2003 Dec; 48(12):3497-502. PubMed ID: 14674000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood dendritic cells in systemic lupus erythematosus exhibit altered activation state and chemokine receptor function.
    Gerl V; Lischka A; Panne D; Grossmann P; Berthold R; Hoyer BF; Biesen R; Bruns A; Alexander T; Jacobi A; Dörner T; Burmester GR; Radbruch A; Hiepe F
    Ann Rheum Dis; 2010 Jul; 69(7):1370-7. PubMed ID: 19854711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotype and function of dendritic cells of patients with systemic lupus erythematosus.
    Crispín JC; Vargas-Rojas MI; Monsiváis-Urenda A; Alcocer-Varela J
    Clin Immunol; 2012 Apr; 143(1):45-50. PubMed ID: 22239954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
    Hänsel A; Günther C; Baran W; Bidier M; Lorenz HM; Schmitz M; Bachmann M; Döbel T; Enk AH; Schäkel K
    J Autoimmun; 2013 Feb; 40():1-8. PubMed ID: 22890025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.
    Robak E; Smolewski P; Wozniacka A; Sysa-Jedrzejowska A; Stepień H; Robak T
    Eur Cytokine Netw; 2004; 15(3):222-30. PubMed ID: 15542447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bcl-2 antagonists kill plasmacytoid dendritic cells from lupus-prone mice and dampen interferon-α production.
    Zhan Y; Carrington EM; Ko HJ; Vikstrom IB; Oon S; Zhang JG; Vremec D; Brady JL; Bouillet P; Wu L; Huang DC; Wicks IP; Morand EF; Strasser A; Lew AM
    Arthritis Rheumatol; 2015 Mar; 67(3):797-808. PubMed ID: 25418983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased numbers of peripheral blood dendritic cells in patients with coronary artery disease are associated with diminished plasma Flt3 ligand levels and impaired plasmacytoid dendritic cell function.
    Van Brussel I; Van Vré EA; De Meyer GR; Vrints CJ; Bosmans JM; Bult H
    Clin Sci (Lond); 2011 May; 120(9):415-26. PubMed ID: 21143200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural interferon-alpha producing cells in systemic lupus erythematosus.
    Rönnblom L; Alm GV
    Hum Immunol; 2002 Dec; 63(12):1181-93. PubMed ID: 12480262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dendritic Cells in Systemic Lupus Erythematosus: From Pathogenic Players to Therapeutic Tools.
    Klarquist J; Zhou Z; Shen N; Janssen EM
    Mediators Inflamm; 2016; 2016():5045248. PubMed ID: 27122656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IgM antibodies against phosphorylcholine promote polarization of T regulatory cells from patients with atherosclerotic plaques, systemic lupus erythematosus and healthy donors.
    Sun J; Lundström SL; Zhang B; Zubarev RA; Steuer J; Gillgren P; Rahman M; Ajeganova S; Liu A; Frostegård J
    Atherosclerosis; 2018 Jan; 268():36-48. PubMed ID: 29175653
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
    Wu P; Wu J; Liu S; Han X; Lu J; Shi Y; Wang J; Lu L; Cao X
    Clin Immunol; 2008 Oct; 129(1):40-8. PubMed ID: 18684674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.
    Garcia-Romo GS; Caielli S; Vega B; Connolly J; Allantaz F; Xu Z; Punaro M; Baisch J; Guiducci C; Coffman RL; Barrat FJ; Banchereau J; Pascual V
    Sci Transl Med; 2011 Mar; 3(73):73ra20. PubMed ID: 21389264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients.
    Jensen MA; Patterson KC; Kumar AA; Kumabe M; Franek BS; Niewold TB
    Ann Rheum Dis; 2013 Apr; 72(4):596-601. PubMed ID: 22904259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.
    Robak E; Sysa-Jedrzejowska A; Robak T; Smolewski P
    Clin Rheumatol; 2006 Mar; 25(2):225-33. PubMed ID: 16432661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon-α-induced B-lymphocyte stimulator expression and mobilization in healthy and systemic lupus erthymatosus monocytes.
    López P; Scheel-Toellner D; Rodríguez-Carrio J; Caminal-Montero L; Gordon C; Suárez A
    Rheumatology (Oxford); 2014 Dec; 53(12):2249-58. PubMed ID: 24942493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.